Compare Coinbase Global, Inc. (COIN) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Coinbase Global, Inc. vs Novartis AG — how do they compare? Coinbase Global, Inc. trades at $150.46 (market cap $39.23B), while Novartis AG trades at $153.53 (market cap $298.18B). The key difference: Novartis AG is far larger — about 7.6× Coinbase Global, Inc.'s market cap, and Novartis AG pays a 3.02% dividend while Coinbase Global, Inc. pays none. Which is the better fit depends on your goals.
| COIN | NVS | |
|---|---|---|
Market Cap | $39.23B | $298.18B |
Sector | Technology | Health |
52-Week High | $387.27 | $168.62 |
52-Week Low | $141.09 | $119.31 |
Enterprise Value | $36.88B | $339.50B |
Dividend Yield | — | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Coinbase Global, Inc.
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
